(Q73089532)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12621691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Serum concentrations of sCD30 and sCD40L in patients with malignant bone tumours (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12621691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

Gerold Holzer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12621691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Thomas Pfandlsteiner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12621691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Harald Blahovec

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12621691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Klemens Trieb

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12621691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Rainer Kotz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12621691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12621691%20AND%20SRC:MED&resulttype=core&format=json

Wiener Medizinische Wochenschrift

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12621691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

153

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12621691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12621691%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

40-42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12621691%20AND%20SRC:MED&resulttype=core&format=json

CD30+ T cells in rheumatoid synovitis: mechanisms of recruitment and functional role

1 November 2019

cites work

1 reference

12 December 2020

High levels of the soluble form of CD30 molecule in rheumatoid arthritis (RA) are expression of CD30+ T cell involvement in the inflamed joints

1 reference

12 December 2020

Serum levels of the soluble form of CD30 molecule as a tumor marker in CD30+ anaplastic large-cell lymphoma

1 reference

12 December 2020

Expression of Ki-1 antigen (CD30) in mesenchymal tumors

1 reference

12 December 2020

Elevated levels of biologically active soluble CD40 ligand in the serum of patients with chronic lymphocytic leukaemia

1 reference

12 December 2020

Soluble CD30 in early rheumatoid arthritis as a predictor of good response to second-line therapy

1 reference

12 December 2020

EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study)-- preliminary results

1 reference

12 December 2020

A system for the surgical staging of musculoskeletal sarcoma

1 reference

12 December 2020

Detection of a soluble form of the CD30 antigen in sera of patients with lymphoma, adult T-cell leukemia and infectious mononucleosis

1 reference

12 December 2020

Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells

1 reference

12 December 2020

1 reference

12 December 2020

Proteins expressed in osteosarcoma and serum levels as prognostic factors

1 reference

12 December 2020

Circulating levels of soluble CD30 and other markers in colorectal cancer patients

1 reference

12 December 2020

A zinc metalloproteinase is responsible for the release of CD30 on human tumor cell lines

1 reference

12 December 2020

[Determination of the degree of morphological regression following chemotherapy in malignant bone tumors]

1 reference

12 December 2020

Tumor size and prognosis in aggressively treated osteosarcoma

1 reference

12 December 2020

Coexpression of CD40 and CD40 ligand in B-cell lymphoma cells

1 reference

12 December 2020

Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay

1 reference

12 December 2020

Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation

1 reference

12 December 2020